Related Experiment Video
Updated: Feb 1, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Emodin Reduces the Activity of (1,3)-β-D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin
1Department of Molecular Biology, The John Paul II Catholic University of Lublin , Lublin , Poland.
Abstract:
Candidiasis is the most common opportunistic yeast infection, with Candida albicans as a paramount causative species. (1,3)- β -D-glucan is one of the three main targets of clinically available antifungal agents used to treat Candida infections. It is one of the most abundant fungal cell wall components. Echinocandins represent the newest class of antifungals affecting cell wall biosynthesis through non-competitive inhibition of (1,3)- β -D-glucan synthase. Therefore, treatment with echinocandins causes defects in fungal cell integrity. In the present study, similar activity of emodin (6-methyl-1,3,8-trihydroxyanthraquinone) has been revealed. Many reports have already shown the antifungal potential of this pleiotropic molecule, including its activity against C. albicans . The aim of this report was to evaluate the activity of emodin towards a new molecular target, i.e. (1,3)- β -D-glucan synthase isolated from Candida cells. Moreover, given the identical mechanism of the activity of both molecules, interaction of emodin with caspofungin was determined. The study revealed that emodin reduced (1,3)- β -D-glucan synthase activity and increased cell wall damage, which was evidenced by both a sorbitol protection assay and an aniline blue staining assay. Furthermore, the synergy testing method showed mainly independence of the action of both tested antifungal agents, i.e. emodin and caspofungin used in combination.
Abstract:
Candidiasis is the most common opportunistic yeast infection, with Candida albicans as a paramount causative species. (1,3)-β-D-glucan is one of the three main targets of clinically available antifungal agents used to treat Candida infections. It is one of the most abundant fungal cell wall components. Echinocandins represent the newest class of antifungals affecting cell wall biosynthesis through non-competitive inhibition of (1,3)-β-D-glucan synthase. Therefore, treatment with echinocandins causes defects in fungal cell integrity. In the present study, similar activity of emodin (6-methyl-1,3,8-trihydroxyanthraquinone) has been revealed. Many reports have already shown the antifungal potential of this pleiotropic molecule, including its activity against C. albicans. The aim of this report was to evaluate the activity of emodin towards a new molecular target, i.e. (1,3)-β-D-glucan synthase isolated from Candida cells. Moreover, given the identical mechanism of the activity of both molecules, interaction of emodin with caspofungin was determined. The study revealed that emodin reduced (1,3)-β-D-glucan synthase activity and increased cell wall damage, which was evidenced by both a sorbitol protection assay and an aniline blue staining assay. Furthermore, the synergy testing method showed mainly independence of the action of both tested antifungal agents, i.e. emodin and caspofungin used in combination.
Insights
Emodin, a natural compound, inhibits (1,3)-β-D-glucan synthase, a key enzyme in Candida cell wall synthesis, similar to echinofungin antifungals. This study reveals emodin
Area of Science:
- Mycology
- Biochemistry
- Pharmacology
Background:
- Candidiasis, a common opportunistic infection, is often caused by *Candida albicans*.
- The fungal cell wall component (1,3)-β-D-glucan is a target for antifungal drugs like echinocandins.
- Echinocandins inhibit (1,3)-β-D-glucan synthase, disrupting cell integrity.
Purpose of the Study:
- To investigate emodin's activity against (1,3)-β-D-glucan synthase in *Candida* cells.
- To determine the interaction between emodin and caspofungin, given their similar mechanisms of action.
Main Methods:
- Enzyme activity assays for (1,3)-β-D-glucan synthase.
- Cell wall damage assessment using sorbitol protection and aniline blue staining assays.
- Synergy testing of emodin and caspofungin in combination.
Main Results:
- Emodin was found to reduce (1,3)-β-D-glucan synthase activity.
- Increased cell wall damage was observed in *Candida* cells treated with emodin.
- Emodin and caspofungin demonstrated largely independent actions when used together.
Conclusions:
- Emodin exhibits antifungal activity by inhibiting (1,3)-β-D-glucan synthase, similar to echinocandins.
- Emodin represents a potential therapeutic agent for candidiasis, targeting fungal cell wall biosynthesis.
- The independent action of emodin and caspofungin suggests potential for combination therapies with reduced drug interactions.
More Related Videos
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
π Molecular Orbitals of 1,3-Butadiene
The simplest conjugated diene is 1,3-butadiene: a four-carbon system where each carbon is sp2-hybridized and has an unhybridized p orbital that contains an unpaired electron. According to molecular orbital theory, atomic orbitals combine to form molecular orbitals such that the number...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Electrophilic 1,2- and 1,4-Addition of HX to 1,3-Butadiene
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

